Literature DB >> 11053443

A role for the polyproline domain of p53 in its regulation by Mdm2.

M Berger1, R Vogt Sionov, A J Levine, Y Haupt.   

Abstract

The p53 protein plays a key role in the cellular response to stress by inducing cell growth arrest or apoptosis. The polyproline region of p53 has been shown to be important for its growth suppression activity. p53 protein lacking the polyproline region has impaired apoptotic activity and altered specificity for certain apoptotic target genes. Here we describe the role of this region in the regulation of p53 by its inhibitor Mdm2. p53 lacking the polyproline region was identified to be more susceptible to inhibition by Mdm2. Furthermore, the absence of this region renders p53 more accessible to ubiquitination, nuclear export, and Mdm2-mediated degradation. This increased sensitivity to Mdm2 results from an enhanced affinity of Mdm2 toward p53 lacking the polyproline region. Our results provide a new explanation for the impaired growth suppression activity of p53 lacking this region. The polyproline region is proposed to be important in the modulation of the inhibitory effects of Mdm2 on p53 activities and stability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053443     DOI: 10.1074/jbc.M008879200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.

Authors:  Michael Berger; Nathalie Stahl; Giannino Del Sal; Ygal Haupt
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.

Authors:  Min-Goo Lee; Jikhyon Han; Seong-In Jeong; Nam-Gu Her; Jin-Hee Lee; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

4.  The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Authors:  Katherine Baran; Mao Yang; Christopher P Dillon; Leona L Samson; Douglas R Green
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

Review 5.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

6.  Karenitecin (bnp1350) and flavopridol as radiosensitizers in malignant glioma.

Authors:  Deepika Rajesh; H Ian Robins; Steven P Howard
Journal:  J Neurol Neuromedicine       Date:  2016

7.  Ontology and diversity of transcript-associated microsatellites mined from a globe artichoke EST database.

Authors:  Davide Scaglione; Alberto Acquadro; Ezio Portis; Christopher A Taylor; Sergio Lanteri; Steven J Knapp
Journal:  BMC Genomics       Date:  2009-09-28       Impact factor: 3.969

8.  Genetic mapping and annotation of genomic microsatellites isolated from globe artichoke.

Authors:  Alberto Acquadro; Sergio Lanteri; Davide Scaglione; Paul Arens; Ben Vosman; Ezio Portis
Journal:  Theor Appl Genet       Date:  2009-03-27       Impact factor: 5.699

Review 9.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

10.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.